Last edition
News about Global Pharma
NEOsphere Join Hands with Kymera Therapeutics for Novel Molecular Glue Target Discovery
NEOsphere Biotechnologies has partnered with Kymera Therapeutics, Inc. focused on unlocking undrugged or poorly drugged disease-causing protein targets that can be only or best addressed by Targeted Protein Degradation.
Global Pharma | 15/05/2024 | By Aishwarya | 330
SprintRay Unveils Pro 2 Desktop 3D Printer and Next-Gen Resins Revolutionising Dental Care
The Pro 2, boasting cutting-edge Optical Panel technology, sets a new standard in precision and throughput.
Global Pharma | 15/05/2024 | By Abha | 606
FDA Accepts PTC Therapeutics' Application for Upstaza Gene Therapy for AADC Deficiency
The BLA acceptance comes with a Priority Review designation, highlighting the urgent need for therapeutic options for patients suffering from AADC deficiency.
Global Pharma | 15/05/2024 | By Abha | 1114
Verismo Therapeutics Gets IND Clearance from FDA for SynKIR-310 in Relapsed/Refractory B-cell NHL
Verismo Therapeutics announced that it has received a notification from the US Food and Drug Administration (FDA) that the Phase 1 clinical trial of SynKIR™-310 for the investigation of NHL may proceed.
Global Pharma | 14/05/2024 | By Manvi | 589
UroShield is an ultrasound-based product designed to prevent bacterial colonization and biofilm on indwelling urinary catheters and increase antibiotic efficacy, ultimately reducing the incidence of catheter-associated urinary tract infections (CAUTI).
Global Pharma | 14/05/2024 | By Manvi | 387
Boehringer Ingelheim Teams Up with Quallent to Expand Access to adalimumab-adbm Injection
Boehringer Ingelheim has signed a deal with Quallent Pharmaceuticals to help expand patient access to citrate-free adalimumab-adbm, Boehringer's biosimilar to Humira (adalimumab), in the US.
Global Pharma | 14/05/2024 | By Aishwarya | 835
Olympus Unveils Advanced Bronchoscopes as Part of EVIS X1 Endoscopy System
Engineered with high-definition imaging capabilities, the newly launched bronchoscopes boast a slender outer diameter compared to their predecessors, facilitating access to more distal airways.
Global Pharma | 14/05/2024 | By Abha | 827
This latest investment brings the total raised by the company to EUR 3.45 million.
Global Pharma | 14/05/2024 | By Abha | 991
AbbVie Partners with Gilgamesh Pharmaceuticals to Develop Therapies for Psychiatric Disorders
AbbVie has signed an option-to-license agreement with Gilgamesh Pharmaceuticals to develop next-generation therapies for psychiatric disorders.
Global Pharma | 14/05/2024 | By Aishwarya | 913
Biocon Signs Semi-Exclusive Distribution and Supply Deal for with Medix
Biocon Ltd. has signed a semi-exclusive distribution and supply agreement with Medix, a specialty pharmaceutical company in Mexico, for the commercialization of its vertically integrated drug product, Liraglutide (gSaxenda).
Global Pharma | 13/05/2024 | By Aishwarya | 385
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy